Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-arm Exploratory Study of Adebrelimab Combined With Famitinib and Chemotherapy as Neoadjuvant Treatment for Thoracic Esophageal Squamous Cell Carcinoma

NCT07796113 is registered in ClinicalTrials.gov with First Affiliated Hospital Xi'an Jiaotong University as lead sponsor.

NCT NCT07796113
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07796113 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-arm Exploratory Study of Adebrelimab Combined With Famitinib and Chemotherapy as Neoadjuvant Treatment for Thoracic Esophageal Squamous Cell Carcinoma
Lead sponsor
First Affiliated Hospital Xi'an Jiaotong University
Phase
Phase 2
Overall status
Recruiting
Start date
October 30, 2025
Completion date
October 30, 2028
Enrollment
24 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal squamous cell carcinoma